Disclosed are the use of one or more lipid compounds in the delivery of nucleic acids, and a lipid-nucleic acid mixture, a pharmaceutical composition or a kit comprising the lipid compound and nucleic acids. The lipid compounds provided in the present invention can promote the absorption of nucleic acids, particularly via oral absorption, and can promote the entry of the nucleic acids at target sites in a subject in need thereof.

This invention provides a composition comprising at least three agents selected from the group consisting of alpha-ketoglutarate, malate, pterostilbene, micro-dosed lithium, glycine, ginger, Rhodiola rosea, acetyl glucosamine, vitamin C, glucosamine, fisetin, L-theanine, oxaloacetate, fumarate, succinate, hyaluronic acid, butyrate, anthocyanins, piperlongumine, quercetin, curcuminoids, caffeine, trehalose, and spermidine. This invention also provides related pharmaceutical compositions, methods for ameliorating hallmarks of aging, and articles of manufacture.

This invention provides a composition comprising at least three agents selected from the group consisting of alpha-ketoglutarate, malate, pterostilbene, micro-dosed lithium, glycine, ginger, Rhodiola rosea, acetyl glucosamine, vitamin C, glucosamine, fisetin, L-theanine, oxaloacetate, fumarate, succinate, hyaluronic acid, butyrate, anthocyanins, piperlongumine, quercetin, curcuminoids, caffeine, trehalose, and spermidine. This invention also provides related pharmaceutical compositions, methods for ameliorating hallmarks of aging, and articles of manufacture.

This invention provides a composition comprising at least three agents selected from the group consisting of alpha-ketoglutarate, malate, pterostilbene, micro-dosed lithium, glycine, ginger, Rhodiola rosea, acetyl glucosamine, vitamin C, glucosamine, fisetin, L-theanine, oxaloacetate, fumarate, succinate, hyaluronic acid, butyrate, anthocyanins, piperlongumine, quercetin, curcuminoids, caffeine, trehalose, and spermidine. This invention also provides related pharmaceutical compositions, methods for ameliorating hallmarks of aging, and articles of manufacture.

A botanical antiviral nutritional supplement includes ground Achillea Millefolium, ground Bryophyllum Pinnatum, ground Sambucus Nigra, ground Neurolaena Lobata, ground Verbascum Thapsus, ground Morinda Citrifolia, ground Prunella Vulgaris, and ground Salvia Officinalis. A method of producing the antiviral nutritional supplement includes drying the botanical ingredients; grinding the dried ingredients; and blending the ground, dried ingredients. The supplement is believed to improve the health of a person infected with a virus and to relieve brain fog.

A botanical antiviral nutritional supplement includes ground Achillea Millefolium, ground Bryophyllum Pinnatum, ground Sambucus Nigra, ground Neurolaena Lobata, ground Verbascum Thapsus, ground Morinda Citrifolia, ground Prunella Vulgaris, and ground Salvia Officinalis. A method of producing the antiviral nutritional supplement includes drying the botanical ingredients; grinding the dried ingredients; and blending the ground, dried ingredients. The supplement is believed to improve the health of a person infected with a virus and to relieve brain fog.

A botanical antiviral nutritional supplement includes ground Achillea Millefolium, ground Bryophyllum Pinnatum, ground Sambucus Nigra, ground Neurolaena Lobata, ground Verbascum Thapsus, ground Morinda Citrifolia, ground Prunella Vulgaris, and ground Salvia Officinalis. A method of producing the antiviral nutritional supplement includes drying the botanical ingredients; grinding the dried ingredients; and blending the ground, dried ingredients. The supplement is believed to improve the health of a person infected with a virus and to relieve brain fog.

A composition is provided. The composition contains: (A) a psychoactive compound selected from the group consisting of psilocybin, psilocin, and combinations thereof; and (B) a supplement selected from the group consisting of an amino acid, a vitamin B6, piracetam, gamma aminobutyric acid (GABA), theobromine, caffeine, resveratrol, and combinations thereof. A method of producing the composition and an oral dosage containing the composition are also provided.

A composition is provided. The composition contains: (A) a psychoactive compound selected from the group consisting of psilocybin, psilocin, and combinations thereof; and (B) a supplement selected from the group consisting of an amino acid, a vitamin B6, piracetam, gamma aminobutyric acid (GABA), theobromine, caffeine, resveratrol, and combinations thereof. A method of producing the composition and an oral dosage containing the composition are also provided.

A method of extracting a Rhodiola plant comprising the steps of harvesting and drying the plant; extracting the alkaloids from the plant in a solvent; filtering the solvent-Rhodiola plant mixture to remove the solvent and extracted alkaloids from a spent plant matter; drying the spent plant matter; purifying and separating the extracted alkaloids from the solvent; and mixing the purified alkaloids back into the dried spent plant matter. Also, products of the method include vaporizing liquids, medicinal compositions, kief compositions, rolling papers, and filters for tobacco and vaporizing equipment comprising the mixture of the purified alkaloids and the dried spent plant matter produced according to the method. Further disclosed is a Rhodiola plant having approximately 1.3-8.57% total phenolic compounds containing 1-3.5% salidrosides and 0.03-3.6% Rosavins.